194 related articles for article (PubMed ID: 28182710)
1. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P
PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710
[TBL] [Abstract][Full Text] [Related]
2. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
[TBL] [Abstract][Full Text] [Related]
4. Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice.
Liu P; Peng L; Zhang H; Tang PM; Zhao T; Yan M; Zhao H; Huang X; Lan H; Li P
Front Physiol; 2018; 9():343. PubMed ID: 29681863
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in
Fan XM; Huang CL; Wang YM; Li N; Liang QL; Luo GA
J Diabetes Res; 2018; 2018():8237590. PubMed ID: 29682583
[TBL] [Abstract][Full Text] [Related]
6. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
[TBL] [Abstract][Full Text] [Related]
7. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy.
Hu J; Fan X; Meng X; Wang Y; Liang Q; Luo G
Planta Med; 2014 Jun; 80(8-9):614-21. PubMed ID: 24853762
[TBL] [Abstract][Full Text] [Related]
10. Tangshen Formula Treatment for Diabetic Kidney Disease by Inhibiting Racgap1-stata5-Mediated Cell Proliferation and Restoring miR-669j-Arntl-Related Circadian Rhythm.
Wang X; Zhao H; Wu X; Xi G; Zhou S
Med Sci Monit; 2018 Nov; 24():7914-7928. PubMed ID: 30394366
[TBL] [Abstract][Full Text] [Related]
11. Protective Role of Tangshen Formula on the Progression of Renal Damage in
Wang Q; Tian X; Zhou W; Wang Y; Zhao H; Li J; Zhou X; Zhang H; Zhao T; Li P
J Diabetes Res; 2020; 2020():3634974. PubMed ID: 33015191
[TBL] [Abstract][Full Text] [Related]
12. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
Trials; 2016 May; 17(1):259. PubMed ID: 27216240
[TBL] [Abstract][Full Text] [Related]
14. Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway.
Chen C; Huang K; Hao J; Huang J; Yang Z; Xiong F; Liu P; Huang H
Mol Cell Endocrinol; 2016 May; 427():45-56. PubMed ID: 26948947
[TBL] [Abstract][Full Text] [Related]
15. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
16. Tangshen Formula alleviates inflammatory injury against aged diabetic kidney disease through modulating gut microbiota composition and related amino acid metabolism.
Chen DQ; Zhang HJ; Zhang W; Feng K; Liu H; Zhao HL; Li P
Exp Gerontol; 2024 Apr; 188():112393. PubMed ID: 38458480
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.
Xu XH; Ding DF; Yong HJ; Dong CL; You N; Ye XL; Pan ML; Ma JH; You Q; Lu YB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4952-4965. PubMed ID: 29164562
[TBL] [Abstract][Full Text] [Related]
18. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
Jin D; Huang WJ; Meng X; Yang F; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
Trials; 2019 Dec; 20(1):756. PubMed ID: 31864393
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice.
Yang S; Chen Y; Duan Y; Ma C; Liu L; Li Q; Yang J; Li X; Zhao B; Wang Y; Qian K; Liu M; Zhu Y; Yang X; Han J
Biomed Pharmacother; 2019 Oct; 118():109389. PubMed ID: 31545275
[TBL] [Abstract][Full Text] [Related]
20. Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects
Li N; Zhao T; Cao Y; Zhang H; Peng L; Wang Y; Zhou X; Wang Q; Li J; Yan M; Dong X; Zhao H; Li P
Front Pharmacol; 2020; 11():623489. PubMed ID: 33584307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]